Background
==========

Portal venous system thrombosis (PVST) refers to the formation of a thrombus within the intrahepatic portal vein branches, main portal vein (MPV), splenic vein (SV), and superior mesenteric vein (SMV) \[[@b1-medscimonit-22-2528],[@b2-medscimonit-22-2528]\]. Given the relatively high prevalence and negative prognostic impact of PVST in liver cirrhosis \[[@b3-medscimonit-22-2528]--[@b6-medscimonit-22-2528]\], understanding the risk factors of PVST is important to optimize the prevention strategy in clinical practice.

Portal vessel wall injury caused by splenectomy may be one of the most important local risk factors of PVST \[[@b7-medscimonit-22-2528]--[@b15-medscimonit-22-2528]\]. Numerous studies confirmed that the incidence of PVST after splenectomy was up to about 50% \[[@b15-medscimonit-22-2528]\]. Notably, splenectomy is widely used for the treatment of cirrhotic portal hypertension and hypersplenism in China \[[@b16-medscimonit-22-2528]\], but not in the West. However, few studies have explored the extent to which the risk of PVST is increased by splenectomy in liver cirrhosis. On the other hand, factor V Leiden and prothrombin G20210A mutations are the major systemic risk factors of PVST in liver cirrhosis \[[@b17-medscimonit-22-2528]\]. Notably, these 2 gene mutations are frequently observed in Western populations \[[@b18-medscimonit-22-2528]\], but rarely in Chinese populations \[[@b19-medscimonit-22-2528],[@b20-medscimonit-22-2528]\]. Taken together, the distribution of risk factors of PVST in liver cirrhosis may be largely different between Western countries and China.

Herein, we analyzed the prevalence and risk factors of PVST in a retrospective cohort of Chinese patients with liver cirrhosis based on contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) scans. Additionally, the effect of PVST on the in-hospital mortality of liver cirrhosis was explored.

Material and Methods
====================

Patients
--------

All patients with a diagnosis of liver cirrhosis who were admitted to our hospital between June 2012 and December 2013 were retrospectively reviewed in this study. At our hospital, the diagnosis of liver cirrhosis was made according to the history of chronic liver diseases, clinical symptoms (i.e., decompensated events) and signs, laboratory tests (i.e., liver function and coagulation tests), and abdominal images (i.e., liver and spleen morphology). If necessary, liver biopsy was performed. All eligible patients underwent contrast-enhanced CT and/or MRI scans to evaluate the patency of portal venous system vessels. Malignancy was excluded. The study protocol was approved by the Medical Ethics Committee of our hospital, approval number (k2014)07.

Clinical and laboratory data
----------------------------

As previously mentioned, our study group had continuously collected the data of cirrhotic patients from our hospital \[[@b21-medscimonit-22-2528]--[@b26-medscimonit-22-2528]\]. Some of them had been included in our previous studies. The primary data were as follows: age, sex, etiology of liver cirrhosis, other diseases, previous history of surgery, abdominal trauma, main clinical presentations (i.e., acute upper gastrointestinal bleeding \[AUGIB\], ascites, and hepatic encephalopathy \[HE\]), red blood cell (RBC), hemoglobin (Hb), white blood cell (WBC), platelet count (PLT), total bilirubin (TBIL), albumin (ALB), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), blood urea nitrogen (BUN), creatinine (Cr), potassium, sodium, prothrombin time (PT), activated partial thromboplastin time (APTT), and international normalized ratio (INR). Notably, the major indications for splenectomy with or without portal azygous devascularization in our patients were splenomegaly and hypersplenism and prevention of portal hypertension-related bleeding. Endoscopic examinations, if any, were reviewed. Severity of esophageal varices at endoscopy was evaluated \[[@b16-medscimonit-22-2528]\]. Several scores/indexes related to the prognosis of liver diseases were also calculated, including Child-Pugh \[[@b27-medscimonit-22-2528]\], model for end-stage of liver disease (MELD) \[[@b28-medscimonit-22-2528]\], AST to PLT ratio index (APRI) \[[@b29-medscimonit-22-2528]\], AST to ALT ratio (AAR) \[[@b30-medscimonit-22-2528]\], FIB-4 \[[@b31-medscimonit-22-2528]\], fibrosis index (FI) \[[@b32-medscimonit-22-2528]\], and King scores \[[@b33-medscimonit-22-2528]\].

Imaging data
------------

Extension of portal venous system vessels referred to the left portal vein branch (LPV), right portal vein branch (RPV), MPV, SV, and SMV. Degree of MPV thrombosis was divided into mural (thrombus occupation \<50%), partial (thrombus occupation \>50%), total (thrombus occupation=100%), and obliterative (MPV became fibrotic cord) \[[@b34-medscimonit-22-2528]\]. Cavernous transformation of the portal vein (CTPV) was also identified. Clinically significant PVST was defined as any 1 of the following conditions: 1) partial MPV thrombosis with SMV thrombosis; or 2) total MPV thrombosis with or without SMV thrombosis \[[@b35-medscimonit-22-2528]\]. Additionally, the maximal diameters of spleen, SV, and MPV, and ascites were also evaluated.

Data analysis
-------------

Continuous data were expressed as mean ± standard deviation (SD) and median (range) and were compared by the independent-sample *t* test. Categorical data were expressed as frequency (percentage) and were compared by the chi-square test or Fisher's exact test. Comparative analyses were performed according to the severity of thrombosis (PVST versus no PVST, partial and total MPV thrombosis versus mural MPV thrombosis and patency, and clinically significant PVST versus no clinically significant PVST). Comparative analyses were further performed after excluding patients who underwent splenectomy. All variables that were statistically significant in the univariate analyses were also entered into the multivariate logistic regression analyses. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to express the association of different variables with PVST. Clinical, laboratory, and imaging data were also compared between PVST patients with and without splenectomy. P value \<0.05 was considered statistically significant. All statistical analyses were performed using SPSS statistical software version 16.0.0.

Results
=======

Patients
--------

A total of 113 cirrhotic patients were included in our study. Patient characteristics are shown in [Table 1](#t1-medscimonit-22-2528){ref-type="table"}. A majority of patients were male (66.4%) and had Child-Pugh class A and B (79.6%). Major etiologies of liver cirrhosis were hepatitis B virus and alcohol abuse. The prevalence of PVST was 16.8% (19/113). MPV thrombosis was observed in 12.4% (14/113) of patients, including mural (n=5, 4.4%), partial (n=6, 5.3%), and total (n=3, 2.7%) thrombosis. Eight (7.1%) patients had a history of splenectomy. Characteristics of patients without splenectomy are shown in [Supplementary Table 1](#s1-medscimonit-22-2528){ref-type="supplementary-material"}. After excluding splenectomy, the prevalence of PVST was 13.3% (14/105).

Risk factors in all patients
----------------------------

### PVST

Patients with PVST had significantly higher proportions of splenectomy and severe esophageal varices, lower RBC, Hb, ALB, and sodium, and higher FI score than those without ([Table 2](#t2-medscimonit-22-2528){ref-type="table"}). Only Hb, but not RBC, was entered into the multivariate analysis, because there was a collinearity between RBC and Hb. The statistical significance was observed as esophageal varices were categorized into 4 grades, but disappeared as it was categorized into 2 grades. Thus, this variable was not entered into the multivariate analysis. Because ALB was 1 component of the FI score, FI score was not entered. Finally, splenectomy (OR=11.494, 95%CI=2.152--61.395, p=0.004) and higher Hb (OR=0.974, 95%CI=0.953--0.996, p=0.019) were the independent predictors of PVST.

### MPV thrombosis \>50%

Patients with MPV thrombosis \>50% had a significantly higher proportion of splenectomy and lower RBC and Hb than those without ([Table 3](#t3-medscimonit-22-2528){ref-type="table"}). Severity of liver dysfunction was not significantly different between them. Only Hb, but not RBC, was entered into the multivariate analysis, because there was a collinearity between RBC and Hb. Finally, both splenectomy (OR=29.987, 95%CI=3.247--276.949, p=0.003) and higher Hb (OR=0.936, 95%CI=0.895--0.980, p=0.004) were the independent predictors of MPV thrombosis \>50%.

### Clinically significant PVST

Patients with clinically significant PVST had significantly higher proportions of splenectomy and ascites and lower RBC and Hb than those without ([Table 4](#t4-medscimonit-22-2528){ref-type="table"}). Only Hb, but not RBC, was entered into the multivariate analysis, because there was a collinearity between RBC and Hb. The statistical significance was observed as ascites were categorized into 3 grades, but disappeared as it was categorized into 2 grades. Thus, this variable was not entered into the multivariate analysis. Finally, both splenectomy (OR=40.415, 95%CI=3.895--419.295, p=0.002) and higher Hb (OR=0.935, 95%CI=0.891--0.982, p=0.007) were the independent predictors of clinically significant PVST.

Risk factors after excluding splenectomy
----------------------------------------

### PVST

After excluding splenectomy, patients with PVST had significantly lower RBC, Hb, ALB, sodium, PT, APTT, INR, MELD score, and FI score, and higher Cr than those without ([Table 5](#t5-medscimonit-22-2528){ref-type="table"}). Given the potential collinearity among variables, only Hb and INR, but not RBC or PT, were entered into the multivariate analysis. Additionally, because Cr and INR were 2 components of the MELD score, MELD score was not entered. Similarly, because ALB was 1 component of the FI score, FI score was not entered. Finally, no variables were identified as independent predictors of PVST.

### MPV thrombosis \>50%

After excluding splenectomy, patients with MPV thrombosis \>50% had significantly lower Hb and higher BUN than those without ([Table 6](#t6-medscimonit-22-2528){ref-type="table"}). Severity of liver dysfunction was not significantly different between them. In the multivariate analysis, only Hb (OR=0.952, 95%CI=0.909--0.997, p=0.035) was an independent predictor of MPV thrombosis \>50%.

### Clinically significant PVST

After excluding splenectomy, patients with clinically significant PVST had a significantly higher proportion of ascites, lower Hb, and higher BUN and FI score than those without ([Table 7](#t7-medscimonit-22-2528){ref-type="table"}). The statistical significance was observed as ascites were categorized into 3 grades, but disappeared as it was categorized into 2 grades. Thus, this variable was not entered into the multivariate analysis. Because ALB was 1 component of the FI score, FI score was not entered. Finally, no variables were identified as independent predictors of clinically significant PVST.

Comparison of characteristics between PVST patients with and without splenectomy
--------------------------------------------------------------------------------

PVST patients with splenectomy had significantly higher proportions of clinically significant PVST and RPV thrombosis, higher PLT, and lower MELD and FIB-4 scores than those without ([Table 8](#t8-medscimonit-22-2528){ref-type="table"}).

Discussion
==========

Our study found that the prevalence of PVST was 16.8% (19/113) in all patients with liver cirrhosis and was 13.3% (14/105) in cirrhotic patients after excluding splenectomy. We are confident about the data, because axial contrast-enhanced CT scans were used to more objectively detect the presence of PVST. Our data are consistent with a review by Fimognari et al. (5--20%) \[[@b4-medscimonit-22-2528]\] and suggest that PVST should be a relatively frequent complication of liver cirrhosis.

The most important finding of our study was that splenectomy was a very strong risk factor for the development of PVST in liver cirrhosis. Their association became closer as PVST was more severe ([Supplementary Figure 1](#s2-medscimonit-22-2528){ref-type="supplementary-material"}). In detail, if the severity of PVST was not restricted, the OR for splenectomy was 10.833 and 11.494 in univariate and multivariate analysis, respectively; if only patients with MPV thrombosis \>50% were analyzed, the OR for splenectomy was 20.000 and 29.987 in univariate and multivariate analysis, respectively; and if only patients with clinically significant PVST were analyzed, the OR for splenectomy was 25.250 and 40.415 in univariate and multivariate analysis, respectively. In addition, our study demonstrated that cirrhotic patients with splenectomy had more severe PVST but less severe liver dysfunction than those without. Thus, splenectomy might be more independent of liver dysfunction in the development of PVST in liver cirrhosis.

Based on these findings, we should fully balance the clinical benefits and adverse effects of splenectomy in liver cirrhosis. The indications for splenectomy in cirrhosis should be clearly specified. On the other hand, low-quality evidence suggested that the pharmacological prophylaxis of PVST in liver cirrhosis should be effective \[[@b36-medscimonit-22-2528]\]. Thus, well-designed randomized studies are needed to accurately identify the candidates for and timing of pharmacological prophylaxis of PVST in cirrhotic patients treated with splenectomy. Certainly, when its clinical significance is explained, the regions should be also taken into account. Splenectomy with porta-azygous devascularization is a major treatment option for portal hypertension and hypersplenism in China and Japan \[[@b7-medscimonit-22-2528],[@b10-medscimonit-22-2528],[@b11-medscimonit-22-2528],[@b16-medscimonit-22-2528],[@b37-medscimonit-22-2528]\]. By comparison, it is rarely recommended by the practice guidelines and consensus from Western countries \[[@b38-medscimonit-22-2528]--[@b40-medscimonit-22-2528]\]. Thus, this finding may be relevant in Western populations.

Theoretically, the portal pressure and risk of portal hypertension-related bleeding may be higher in cirrhotic patients with PVST than in those without. If so, the preventive and therapeutic strategy of variceal bleeding should be actively applied in patients with PVST. In agreement with this, we found a significantly higher proportion of high-risk varices in patients with PVST than in those without, but the statistical significance disappeared in other subgroup analyses due to the relatively small number of patients with MPV thrombosis \>50% and clinically significant PVST ([Supplementary Figure 2](#s3-medscimonit-22-2528){ref-type="supplementary-material"}). On the other hand, all patients with clinically significant PVST who underwent endoscopic examinations had high-risk varices. Therefore, they should undergo careful variceal eradication before anticoagulation is initiated for the treatment of PVST in cirrhosis \[[@b41-medscimonit-22-2528]--[@b45-medscimonit-22-2528]\]. All analyses demonstrated that cirrhotic patients with PVST had significantly lower Hb than those without, which suggested a larger amount of upper gastrointestinal bleeding in patients with PVST. However, the prevalence of AUGIB was statistically similar between patients with and without PVST.

Regardless of splenectomy, all analyses showed no statistically significant association between Child-Pugh score and PVST in liver cirrhosis. Notably, after excluding patients with splenectomy, cirrhotic patients with PVST might have a higher Child-Pugh score than those without. Similarly, all but 1 analyses showed no significant association of MELD score with PVST. Notably, after excluding patients with splenectomy, MELD score was higher in cirrhotic patients PVST than in those without. Taken together, we should not neglect the role of liver dysfunction in the development of PVST in liver cirrhosis.

A previous study by D'Amico et al. found that PVST is significantly associated with worse short-term prognosis of cirrhotic patients with AUGIB \[[@b46-medscimonit-22-2528]\]. By comparison, our study population was not restricted to AUGIB. In this setting, the in-hospital mortality was not significantly different between patients with and without PVST. Additionally, long-term outcome was lacking in our study.

Several other limitations should be clarified. First, the concentrations of coagulation and anticoagulation factors were not tested in any patients. Second, several studies suggested that abdominal surgery, such as colon and rectal surgery and sleeve gastrectomy, might increase the risk of PVST \[[@b47-medscimonit-22-2528],[@b48-medscimonit-22-2528]\]. However, we did not identify any statistically significant association of appendicectomy and gastric and colonic surgery with the development of PVST in liver cirrhosis. It should be noted that very few patients underwent such abdominal surgery. Finally, the statistical power of our study may have been inadequate.

Conclusions
===========

Splenectomy increases by at least 10-fold the risk of PVST in liver cirrhosis. Given the effect of PVST on the outcomes of liver cirrhosis, physicians should fully balance the benefits and risks of splenectomy for the treatment of portal hypertension and hypersplenism in liver cirrhosis. Further studies are warranted to explore the prevention of PVST after splenectomy.

Supplementary Material
======================

###### 

Characteristics of patients after excluding splenectomy.

  Variables                                           N     Values
  --------------------------------------------------- ----- ---------------------------------------
  Age (years)                                         105   55.21±13.01; 55.19 (22.14--85.46)
  Sex (Male/Female) -- n.                             105   71 (67.6%)/34 (32.4%)
  Etiology of liver diseases -- n.                    105   
   -- Hepatitis B virus alone                               32 (30.5%)
   -- Hepatitis C virus alone                               7 (6.7%)
   -- Hepatitis B + C virus                                 3 (2.9%)
   -- Alcohol                                               30 (28.6%)
   -- Hepatitis B virus + Alcohol                           7 (6.7%)
   -- Hepatitis C virus + Alcohol                           1 (1%)
   -- Autoimmunity                                          5 (4.8%)
   -- Drug related                                          2 (1.9%)
   -- Unknown                                               18 (17.1%)
  Disease history -- n.                               105   
   -- Diabetes                                              13 (12.4%)
   -- Coronary heart disease                                8 (7.6%)
   -- Ischemic stroke                                       5 (4.8%)
   -- Arterial hypertension                                 9 (8.6%)
   -- Deep vein thrombosis                                  1 (1.0%)
  Surgery history -- n.                               105   
   -- Splenectomy                                           0 (0%)
   -- Appendicectomy                                        3 (2.9%)
   -- Gastric surgery                                       2 (1.8%)
   -- Colonic surgery                                       1 (1%)
   -- Orthopedic surgery                                    3 (2.9%)
  Abdominal trauma history -- n.                      105   1 (1%)
  Acute upper gastrointestinal bleeding -- n.         105   17 (16.2%)
  Ascites at CT scans -- n.                           105   
   -- No                                                    46 (43.8%)
   -- Mild                                                  26 (24.8%)
   -- Moderate-Severe                                       33 (31.4%)
  Hepatic encephalopathy -- n.                        104   6 (5.8%)
  Esophageal varices at endoscopy -- n.               42    
   -- No                                                    10 (23.8%)
   -- Mild                                                  2 (4.8%)
   -- Moderate                                              9 (21.4%)
   -- Severe                                                21 (50.0%)
  Red blood cell (10^12^/L)                           102   3.42±0.88; 3.38 (1.19--5.27)
  Hemoglobin (g/L)                                    102   106.18±30.30; 107 (42--170)
  White blood cell (10^9^/L)                          102   4.96±3.21; 4.15 (1.5--20.5)
  Platelet count (10^9^/L)                            102   92.97±76.65; 73.5 (11--545)
  Total bilirubin (umol/L)                            104   48.44±71.87; 23.8 (5.1--436.5)
  Albumin (g/L)                                       103   32.33±6.67; 32.2 (11.7--44.3)
  Alanine aminotransferase (U/L)                      104   51.61±63.08; 33 (8--429)
  Aspartate aminotransferase (U/L)                    104   74.13±98.12; 47 (10--889)
  Alakaline phosphatate (U/L)                         104   117.67±80.09; 92 (34--524.4)
  Gamma-glutamyl transpeptidase (U/L)                 104   159.73±222.69; 68.5 (12--1130)
  Blood urea nitrogen (mmol/L)                        102   5.80±2.60; 5.26 (1.73--17.18)
  Creatinine (umol/L)                                 102   59.42±21.61; 57 (29--151)
  Potassium (mmol/L)                                  103   4.04±0.47; 4 (3.01--5.43)
  Sodium (mmol/L)                                     103   138.02±6.50; 139.2 (83--144.5)
  Prothrombin time (seconds)                          103   16.34±6.55; 14.8 (11.4--62.8)
  Activated partial thromboplastin time (seconds)     103   45.13±16.53; 42.1 (29.9--180)
  International normalized ratio                      103   1.35±0.84; 1.16 (0.77--7.96)
  Child-Pugh score                                    100   7.64±2.07; 8 (5--12)
  Child-Pugh class A/B/C                              100   37 (37%)/40 (40%)/23 (23%)
  MELD score                                          100   6.23±7.04; 4.86 (−5.20--34.52)
  APRI score                                          102   3.28±6.18; 1.69 (0.10--56.99)
  AAR score                                           104   1.33±1.70; 0.72 (0.22--10.08)
  FIB-4 score                                         102   9.42±9.68; 6.97 (0.38--61.59)
  FI score                                            101   −25.31±6.91; −25.24 (−39.25 -- −3.85)
  King score                                          101   122.54±310.00; 46.97 (1.77--2589.47)
  Portal vein system thrombosis -- n.                 105   14 (13.3%)
  According to the location of thrombosis                   
   -- Left portal vein branch thrombosis -- n.        105   4 (3.8%)
   -- Right portal vein branch thrombosis -- n.       105   2 (1.9%)
   -- Main portal vein thrombosis -- n.               105   9 (8.6%)
   -- Superior mesenteric vein thrombosis -- n.       105   5 (4.8%)
   -- Splenic vein thrombosis -- n.                   105   4 (3.8%)
  According to the degree of MPV thrombosis                 
   -- Mural thrombosis (\<50%) -- n.                  105   4 (3.8%)
   -- Partial thrombosis (\>50%) -- n.                105   4 (3.8%)
   -- Total thrombosis (100%) -- n.                   105   1 (11.1%)
  Cavernous transformation of the portal vein -- n.   105   3 (2.9%)
  Clinically significant PVST -- n.                   105   4 (3.8%)
  Maximal diameter of spleen (mm)                     105   140.27±30.77; 138.2 (83.8--240.9)
  Maximal diameter of splenic vein (mm)               105   10.68±3.83; 10.3 (4.3--29.6)
  Maximal diameter of main portal vein (mm)           105   18.34±5.18; 18 (0--31)
  In-hospital mortality -- n.                         105   4 (3.8%)

###### 

The ORs for splenectomy in the development of PVST according to the severity of PVST.

###### 

The proportions of degree of esophageal varices in cirrhotic patients with and without PVST. (A) All patients. (B) Patients after excluding splenectomy.
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###### 

Characteristics of all patients.

  Variables                                           N     Values
  --------------------------------------------------- ----- ---------------------------------------
  Age (years)                                         113   55.15±12.87; 55.18 (22.14--85.46)
  Sex (Male/Female) -- n.                             113   75 (66.4%)/38 (33.6%)
  Etiology of liver diseases -- n.                    113   
   -- Hepatitis B virus alone                               34 (30.1%)
   -- Hepatitis C virus alone                               7 (6.2%)
   -- Hepatitis B + C virus                                 4 (3.5%)
   -- Alcohol                                               30 (26.5%)
   -- Hepatitis B virus + Alcohol                           9 (8.0%)
   -- Hepatitis C virus + Alcohol                           1 (0.9%)
   -- Hepatitis B + C virus + Alcohol                       1 (0.9%)
   -- Autoimmunity                                          6 (5.3%)
   -- Drug related                                          2 (1.8%)
   -- Unknown                                               20 (17.7%)
  Disease history -- n.                               113   
   -- Diabetes                                              15 (13.3%)
   -- Coronary heart disease                                8 (7.1%)
   -- Ischemic stroke                                       5 (4.4%)
   -- Arterial hypertension                                 9 (8.0%)
   -- Deep vein thrombosis                                  1 (0.9%)
  Surgery history -- n.                               113   
   -- Splenectomy                                           8 (7.1%)
   -- Appendicectomy                                        3 (2.7%)
   -- Gastric surgery                                       2 (1.8%)
   -- Colonic surgery                                       1 (0.9%)
   -- Orthopedic surgery                                    3 (2.7%)
  Abdominal trauma history -- n.                      113   1 (0.9%)
  Acute upper gastrointestinal bleeding -- n.         113   19 (16.8%)
  Ascites at CT scans -- n.                           113   
   -- No                                                    49 (43.4%)
   -- Mild                                                  30 (26.5%)
   -- Moderate-Severe                                       34 (30.1%)
  Hepatic encephalopathy -- n.                        112   6 (5.4%)
  Esophageal varices at endoscopy -- n.               48    
   -- No                                                    10 (20.8%)
   -- Mild                                                  3 (6.2%)
   -- Moderate                                              10 (20.8%)
   -- Severe                                                25 (52.1%)
  Red blood cell (10^12^/L)                           110   3.39±0.88; 3.36 (1.19--5.27)
  Hemoglobin (g/L)                                    110   105.15±30.48; 106.00 (42.00--170.00)
  White blood cell (10^9^/L)                          110   5.10±3.22; 4.40 (1.50--20.50)
  Platelet count (10^9^/L)                            110   101.37±82.67; 75.00 (11.00--545.00)
  Total bilirubin (umol/L)                            112   46.79±69.82; 22.50 (5.10--436.50)
  Albumin (g/L)                                       111   32.27±6.53; 31.70 (11.70--44.30)
  Alanine aminotransferase (U/L)                      112   51.74±61.61; 33.00 (8.00--429.00)
  Aspartate aminotransferase (U/L)                    112   74.18±95.92; 47.00 (10.00--889.00)
  Alakaline phosphatate (U/L)                         112   120.88±86.96; 92.00 (34.00--524.40)
  Gamma-glutamyl transpeptidase (U/L)                 112   154.86±216.00; 66.00 (12.00--1130.00)
  Blood urea nitrogen (mmol/L)                        110   5.70±2.58; 5.09 (1.73--17.18)
  Creatinine (umol/L)                                 110   58.85±21.00; 55.65 (29.00--151.00)
  Potassium (mmol/L)                                  110   4.04±0.47; 4.00 (3.01--5.43)
  Sodium (mmol/L)                                     110   138.07±6.32; 138.80 (83.00--144.50)
  Prothrombin time (seconds)                          111   16.21±6.35; 14.70 (11.40--62.80)
  Activated partial thromboplastin time (seconds)     111   44.56±16.09; 42.00 (29.90--180.00)
  International normalized ratio                      111   1.34±0.81; 1.16 (0.77--7.96)
  Child-Pugh score                                    108   7.61±2.02; 7.50 (5.00--12.00)
  Child-Pugh class A/B/C                              108   40 (37.0%)/45 (41.7%)/23 (21.3%)
  MELD score                                          108   5.93±6.95; 4.73 (−5.20--34.52)
  APRI score                                          110   3.12±5.98; 1.67 (0.10--56.99)
  AAR score                                           112   1.27±1.66; 0.69 (0.20--10.08)
  FIB-4 score                                         110   8.94±9.49; 5.85 (0.38--61.59)
  FI score                                            109   −25.33±6.73; −25.24 (−39.25 -- −3.85)
  King score                                          109   115.74±299.39; 43.31 (1.77--2589.47)
  Portal vein system thrombosis -- n.                 113   19 (16.8%)
  According to the location of thrombosis                   
   -- Left portal vein branch thrombosis -- n.        113   7 (6.2%)
   -- Right portal vein branch thrombosis -- n.       113   6 (5.3%)
   -- Main portal vein thrombosis -- n.               113   14 (12.4%)
   -- Superior mesenteric vein thrombosis -- n.       113   9 (8.0%)
   -- Splenic vein thrombosis -- n.                   113   4 (3.5%)
  According to the degree of MPV thrombosis                 
   -- Mural thrombosis (\<50%) -- n.                  113   5 (4.4%)
   -- Partial thrombosis (\>50%) -- n.                113   6 (5.3%)
   -- Total thrombosis (100%) -- n.                   113   3 (2.7%)
  Cavernous transformation of the portal vein -- n.   113   5 (4.4%)
  Clinically significant PVST -- n.                   113   8 (7.1%)
  Maximal diameter of spleen (mm)                     105   140.27±30.77; 138.20 (83.8--240.9)
  Maximal diameter of splenic vein (mm)               105   10.68±3.83; 10.3 (4.3--29.6)
  Maximal diameter of main portal vein (mm)           113   18.38±5.44; 17.90 (0--35.4)
  In-hospital mortality -- n.                         113   4 (3.5%)

###### 

Overall comparison between patients with and without PVST.

  Variables                                         PVST   No PVST                         P value                                
  ------------------------------------------------- ------ ------------------------------- --------- ---------------------------- -------------
  Age (years)                                       19     53.14±12.21                     94        55.56±13.02                  0.457
  Sex (Male/Female) -- n.                           19     13 (68.4%)/6 (31.6%)            94        62 (66%)/32 (34%)            0.836
  Etiology of liver diseases -- n.                  19                                     94                                     0.916
   -- Hepatitis B virus alone                              5 (26.3%)                                 29 (30.9%)                   
   -- Hepatitis C virus alone                              1 (5.3%)                                  6 (6.4%)                     
   -- Hepatitis B + C virus                                1 (5.3%)                                  3 (3.2%)                     
   -- Alcohol                                              5 (26.3%)                                 24 (26.6%)                   
   -- Hepatitis B virus + Alcohol                          3 (15.8%)                                 6 (6.4%)                     
   -- Hepatitis C virus + Alcohol                          0 (0%)                                    1 (1.1%)                     
   -- Autoimmunity                                         1 (5.3%)                                  5 (5.3%)                     
   -- Drug related                                         0 (0%)                                    2 (2.1%)                     
   -- Unknown                                              3 (15.8%)                                 17 (18.1%)                   
  Disease history -- n.                             19                                     94                                     
   -- Diabetes                                             3 (15.8%)                                 12 (12.8%)                   0.723
   -- Coronary heart disease                               0 (0%)                                    8 (8.5%)                     0.187
   -- Ischemic stroke                                      1 (5.3%)                                  4 (4.3%)                     0.846
   -- Arterial hypertension                                0 (0%)                                    9 (9.6%)                     0.160
   -- Deep vein thrombosis                                 0 (0%)                                    1 (1.1%)                     0.652
  Surgery history -- n.                             19                                     94                                     
   -- Splenectomy                                          5 (26.3%)                                 3 (3.2%)                     **\<0.001**
   -- Appendicectomy                                       0 (0%)                                    3 (3.2%)                     1.000
   -- Gastric surgery                                      0 (0%)                                    2 (2.1%)                     1.000
   -- Colonic surgery                                      0 (0%)                                    1 (1.1%)                     1.000
   -- Orthopedic surgery                                   0 (0%)                                    3 (3.2%)                     1.000
  Abdominal trauma history -- n.                    19     0 (0%)                          94        1 (1.1%)                     0.652
  Acute upper gastrointestinal bleeding -- n.       19     3 (15.8%)                       94        16 (17.0%)                   0.896
  Ascites at CT scans -- n.                         19                                     94                                     0.068
   -- No                                                   5 (26.3%)                                 44 (46.8%)                   
   -- Mild                                                 9 (47.4%)                                 21 (22.3%)                   
   -- Moderate-Severe                                      5 (26.3%)                                 29 (30.9%)                   
  Hepatic encephalopathy -- n.                      19     2 (10.5%)                       93        4 (4.3%)                     0.272
  Esophageal varices at endoscopy -- n.             10                                     38                                     **0.047**
   -- No                                                   0 (0%)                                    10 (26.3%)                   
   -- Mild                                                 2 (20.0%)                                 1 (2.6%)                     
   -- Moderate                                             1 (10.0%)                                 9 (23.7%)                    
   -- Severe                                               7 (70.0%)                                 18 (47.4%)                   
  Red blood cell (10^12^/L)                         18     2.86±0.64                       92        3.49±0.88                    **0.004**
  Hemoglobin (g/L)                                  18     84.39±26.89                     92        109.21±29.59                 **0.001**
  White blood cell (10^9^/L)                        18     5.24±3.07                       92        5.08±3.26                    0.844
  Platelet count (10^9^/L)                          18     110.33±102.15                   92        99.62±78.85                  0.617
  Total bilirubin (umol/L)                          19     55.52±97.61                     93        45.01±63.23                  0.552
  Albumin (g/L)                                     19     29.41±6.64                      92        32.87±6.39                   **0.035**
  Alanine aminotransferase (U/L)                    19     49.84±58.83                     93        52.13±62.46                  0.884
  Aspartate aminotransferase (U/L)                  19     63.74±55.91                     93        76.31±102.29                 0.605
  Alakaline phosphatate (U/L)                       19     132.92±124.27                   93        118.42±77.88                 0.510
  Gamma-glutamyl transpeptidase (U/L)               19     132.11±185.47                   93        159.51±222.33                0.617
  Blood urea nitrogen (mmol/L)                      18     6.20±3.30                       92        5.61±2.42                    0.377
  Creatinine (umol/L)                               18     65.06±26.90                     92        57.64±19.60                  0.171
  Potassium (mmol/L)                                18     4.04±0.46                       92        4.04±0.46                    0.954
  Sodium (mmol/L)                                   18     135.03±13.43                    92        138.66±3.50                  **0.025**
  Prothrombin time (seconds)                        18     18.71±11.39                     93        15.73±4.77                   0.068
  Activated partial thromboplastin time (seconds)   18     49.36±33.45                     93        43.63±9.87                   0.168
  International normalized ratio                    18     1.68±1.60                       93        1.27±0.54                    0.052
  Child-Pugh score                                  18     8.28±1.74                       90        7.48±2.06                    0.126
  Child-Pugh class A/B/C                            18     4 (22.2%)/9 (50.0%)/5 (27.8%)   90        36 (40%)/36 (40%)/18 (20%)   0.356
  MELD score                                        18     7.94±8.70                       90        5.53±6.54                    0.181
  APRI score                                        18     2.21±2.07                       92        3.29±6.47                    0.487
  AAR score                                         19     1.16±2.20                       93        1.30±1.54                    0.740
  FIB-4 score                                       18     7.39±5.04                       92        9.25±10.13                   0.451
  FI score                                          18     −22.19±7.05                     91        −25.96±6.53                  **0.029**
  King score                                        18     100.93±218.90                   91        118.67±313.78                0.820
  Maximal diameter of spleen (mm)                   14     153.19±37.98                    91        138.28±29.25                 0.092
  Maximal diameter of splenic vein (mm)             14     11.05±4.44                      91        10.63±3.76                   0.703
  Maximal diameter of main portal vein (mm)         19     17.68±6.86                      94        18.52±5.13                   0.542
  In-hospital mortality -- n.                       19     1 (5.3%)                        94        3 (3.2%)                     0.656

###### 

Overall comparison between patients with and without MPV thrombosis \>50%.

  Variables                                         MPV thrombosis \>50%   MPV thrombosis \<50% and MPV patency   P value                                      
  ------------------------------------------------- ---------------------- -------------------------------------- --------- ---------------------------------- -------------
  Age (years)                                       9                      57.68±13.95                            104       54.93±12.82                        0.542
  Sex (Male/Female) -- n.                           9                      5 (55.6%)/4 (44.4%)                    104       70 (67.3%)/34 (32.7%)              0.474
  Etiology of liver diseases -- n.                  9                                                             104                                          0.740
   -- Hepatitis B virus alone                                              2 (22.2%)                                        32 (30.8%)                         
   -- Hepatitis C virus alone                                              0 (0%)                                           7 (6.7%)                           
   -- Hepatitis B + C virus                                                1 (1.1%)                                         3 (2.9%)                           
   -- Alcohol                                                              2 (22.2%)                                        28 (26.9%)                         
   -- Hepatitis B virus + Alcohol                                          2 (22.2%)                                        7 (6.7%)                           
   -- Hepatitis C virus + Alcohol                                          0 (0%)                                           1 (1.0%)                           
   -- Autoimmunity                                                         0 (0%)                                           6 (5.8%)                           
   -- Drug related                                                         0 (0%)                                           2 (1.9%)                           
   -- Unknown                                                              2 (22.2%)                                        18 (17.3%)                         
  Disease history -- n.                             9                                                             104                                          
   -- Diabetes                                                             2 (22.2%)                                        13 (12.5%)                         0.410
   -- Coronary heart disease                                               0 (0%)                                           8 (7.7%)                           0.388
   -- Ischemic stroke                                                      1 (11.1%)                                        4 (4.6%)                           0.309
   -- Arterial hypertension                                                0 (0%)                                           9 (8.7%)                           0.358
   -- Deep vein thrombosis                                                 0 (0%)                                           1 (1.0%)                           0.768
  Surgery history -- n.                             9                                                             104                                          
   -- Splenectomy                                                          4 (44.4%)                                        4 (3.8%)                           **\<0.001**
   -- Appendicectomy                                                       0 (0%)                                           3 (2.9%)                           0.606
   -- Gastric surgery                                                      0 (0%)                                           2 (1.9%)                           0.675
   -- Colonic surgery                                                      0 (0%)                                           1 (1.0%)                           0.768
   -- Orthopedic surgery                                                   0 (0%)                                           3 (2.9%)                           0.606
  Abdominal trauma history -- n.                    9                      0 (0%)                                 104       1 (1.0%)                           0.768
  Acute upper gastrointestinal bleeding -- n.       9                      1 (11.1%)                              104       18 (17.3%)                         0.633
  Ascites at CT scans -- n.                         9                                                             104                                          0.065
   -- No                                                                   1 (11.1%)                                        48 (46.2%)                         
   -- Mild                                                                 5 (55.6%)                                        25 (24.0%)                         
   -- Moderate-Severe                                                      3 (33.3%)                                        31 (29.8%)                         
  Hepatic encephalopathy -- n.                      9                      0 (0%)                                 103       6 (5.8%)                           0.457
  Esophageal varices at endoscopy -- n.             7                                                             41                                           0.057
   -- No                                                                   0 (0%)                                           10 (24.4%)                         
   -- Mild                                                                 0 (0%)                                           3 (7.3%)                           
   -- Moderate                                                             0 (0%)                                           10 (24.4%)                         
   -- Severe                                                               7 (100%)                                         18 (43.9%)                         
  Red blood cell (10^12^/L)                         9                      2.70±0.37                              101       3.45±0.88                          **0.013**
  Hemoglobin (g/L)                                  9                      70.22±12.85                            101       108.26±29.66                       **\<0.001**
  White blood cell (10^9^/L)                        9                      4.70±3.17                              101       5.14±3.23                          0.698
  Platelet count (10^9^/L)                          9                      136.33±122.15                          101       98.26±78.33                        0.187
  Total bilirubin (umol/L)                          9                      17.77±15.02                            103       49.33±72.15                        0.195
  Albumin (g/L)                                     9                      29.94±7.21                             102       32.48±6.47                         0.266
  Alanine aminotransferase (U/L)                    9                      28.33±26.81                            103       53.79±63.42                        0.236
  Aspartate aminotransferase (U/L)                  9                      39.11±43.24                            103       77.24±98.74                        0.255
  Alakaline phosphatate (U/L)                       9                      74.82±42.70                            103       124.90±88.78                       0.098
  Gamma-glutamyl transpeptidase (U/L)               9                      33.78±23.30                            103       165.44±222.09                      0.079
  Blood urea nitrogen (mmol/L)                      9                      6.43±4.57                              101       5.64±2.35                          0.380
  Creatinine (umol/L)                               9                      56.24±15.84                            101       59.08±21.45                        0.699
  Potassium (mmol/L)                                9                      4.01±0.35                              101       4.05±0.47                          0.842
  Sodium (mmol/L)                                   9                      138.64±2.85                            101       138.02±6.54                        0.778
  Prothrombin time (seconds)                        9                      15.78±3.02                             102       16.25±6.57                         0.832
  Activated partial thromboplastin time (seconds)   9                      39.22±7.22                             102       45.03±16.59                        0.302
  International normalized ratio                    9                      1.28±0.33                              102       1.34±0.84                          0.824
  Child-Pugh score                                  9                      7.67±1.41                              99        7.61±2.07                          0.932
  Child-Pugh class A/B/C                            9                      2 (22.2%)/6 (66.7%)/1 (11.1%)          99        38 (38.4%) 39 (39.4%)/22 (22.2%)   0.282
  MELD score                                        9                      3.11±5.58                              99        6.19±7.03                          0.205
  APRI score                                        9                      1.14±0.92                              101       3.29±6.21                          0.303
  AAR score                                         9                      0.48±0.31                              103       1.34±1.71                          0.543
  FIB-4 score                                       9                      5.37±3.89                              101       9.26±9.78                          0.240
  FI score                                          9                      −23.31±7.63                            100       −25.52±6.66                        0.348
  King score                                        9                      34.26±28.62                            100       123.08±311.55                      0.396
  Maximal diameter of spleen (mm)                   5                      158.50±48.02                           100       139.36±29.73                       0.176
  Maximal diameter of splenic vein (mm)             5                      11.74±4.04                             100       10.63±3.84                         0.530
  Maximal diameter of main portal vein (mm)         9                      18.64±8.98                             104       18.36±5.09                         0.881
  In-hospital mortality -- n.                       9                      0 (0%)                                 104       4 (3.8%)                           0.549

###### 

Overall comparison between patients with and without clinically significant PVST.

  Variables                                         Clinically significant PVST   No clinically significant PVST   P value                                
  ------------------------------------------------- ----------------------------- -------------------------------- --------- ---------------------------- -------------
  Age (years)                                       8                             58.47±14.69                      105       54.90±12.76                  0.451
  Sex (Male/Female) -- n.                           8                             4 (50%)/4 (50%)                  105       71 (67.6%)/34 (32.4%)        0.309
  Etiology of liver diseases -- n.                  8                                                              105                                    0.595
   -- Hepatitis B virus alone                                                     2 (25%)                                    32 (30.5%)                   
   -- Hepatitis C virus alone                                                     0 (0%)                                     7 (6.7%)                     
   -- Hepatitis B + C virus                                                       1 (12.5%)                                  3 (2.9%)                     
   -- Alcohol                                                                     1 (12.5%)                                  29 (27.6%)                   
   -- Hepatitis B virus + Alcohol                                                 2 (25%)                                    7 (6.7%)                     
   -- Hepatitis C virus + Alcohol                                                 0 (0%)                                     1 (1.0%)                     
   -- Autoimmunity                                                                0 (0%)                                     6 (5.6%)                     
   -- Drug related                                                                0 (0%)                                     2 (1.9%)                     
   -- Unknown                                                                     2 (25%)                                    18 (17.1%)                   
  Disease history -- n.                             8                                                              105                                    
   -- Diabetes                                                                    2 (25%)                                    13 (12.4%)                   0.311
   -- Coronary heart disease                                                      0 (0%)                                     8 (7.6%)                     1.000
   -- Ischemic stroke                                                             1 (12.5%)                                  4 (3.8%)                     0.312
   -- Arterial hypertension                                                       0 (0%)                                     9 (8.6%)                     1.000
   -- Deep vein thrombosis                                                        0 (0%)                                     1 (1.1%)                     1.000
  Surgery history -- n.                             8                                                              105                                    
   -- Splenectomy                                                                 4 (50%)                                    4 (3.8%)                     **\<0.001**
   -- Appendicectomy                                                              0 (0%)                                     3 (2.9%)                     1.000
   -- Gastric surgery                                                             0 (0%)                                     2 (1.9%)                     1.000
   -- Colonic surgery                                                             0 (0%)                                     1 (1.0%)                     1.000
   -- Orthopedic surgery                                                          0 (0%)                                     3 (3.2%)                     1.000
  Abdominal trauma history -- n.                    8                             0 (0%)                           105       1 (1.1%)                     1.000
  Acute upper gastrointestinal bleeding -- n.       8                             1 (12.5%)                        105       18 (17.1%)                   1.000
  Ascites at CT scans -- n.                         8                                                              105                                    **0.046**
   -- No                                                                          1 (12.5%)                                  48 (45.7%)                   
   -- Mild                                                                        5 (62.5%)                                  25 (23.8%)                   
   -- Moderate-Severe                                                             2 (25%)                                    32 (30.5%)                   
  Hepatic encephalopathy -- n.                      8                             0 (0%)                           105       6 (5.8%)                     1.000
  Esophageal varices at endoscopy -- n.             6                                                              42                                     0.098
   -- No                                                                          0 (0%)                                     10 (23.8%)                   
   -- Mild                                                                        0 (0%)                                     3 (7.1%)                     
   -- Moderate                                                                    0 (0%)                                     10 (23.8%)                   
   -- Severe                                                                      6 (100%)                                   19 (45.2%)                   
  Red blood cell (10^12^/L)                         8                             2.71±0.39                        102       3.44±0.88                    **0.022**
  Hemoglobin (g/L)                                  8                             70±13.72                         102       107.90±29.73                 **0.001**
  White blood cell (10^9^/L)                        8                             5.06±3.18                        102       65.10±3.23                   0.972
  Platelet count (10^9^/L)                          8                             151.38±121.35                    102       97.45±78.37                  0.076
  Total bilirubin (umol/L)                          8                             18.78±15.73                      104       48.95±71.91                  0.241
  Albumin (g/L)                                     8                             28.89±6.92                       103       32.54±6.46                   0.129
  Alanine aminotransferase (U/L)                    8                             30.5±27.81                       104       53.38±63.25                  0.314
  Aspartate aminotransferase (U/L)                  8                             42.25±45.11                      104       76.63±98.45                  0.331
  Alakaline phosphatate (U/L)                       8                             78.18±44.36                      104       124.17±88.67                 0.150
  Gamma-glutamyl transpeptidase (U/L)               8                             34.88±24.65                      104       164.09±221.44                0.103
  Blood urea nitrogen (mmol/L)                      8                             6.58±4.86                        102       5.64±2.34                    0.322
  Creatinine (umol/L)                               8                             56.9±16.81                       102       59.00±21.36                  0.786
  Potassium (mmol/L)                                8                             3.95±0.31                        102       4.05±0.47                    0.541
  Sodium (mmol/L)                                   8                             138.45±2.98                      102       138.04±6.51                  0.861
  Prothrombin time (seconds)                        8                             15.9±3.21                        103       16.23±6.54                   0.887
  Activated partial thromboplastin time (seconds)   8                             38.31±7.14                       103       45.04±16.50                  0.256
  International normalized ratio                    8                             1.29±0.35                        103       1.34±0.84                    0.877
  Child-Pugh score                                  8                             7.75±1.49                        100       7.6±2.06                     0.841
  Child-Pugh class A/B/C                            8                             2 (25.0%)/5 (62.5%)/1 (12.5%)    100       38 (38%)/40 (40%)/22 (22%)   0.460
  MELD score                                        8                             3.45±5.86                        100       6.13±7.02                    0.296
  APRI score                                        8                             1.01±0.89                        102       3.28±6.18                    0.302
  AAR score                                         8                             0.48±0.33                        104       1.33±1.70                    0.160
  FIB-4 score                                       8                             4.34±2.57                        102       9.30±9.75                    0.156
  FI score                                          8                             −22.40±7.63                      101       −25.57±6.64                  0.202
  King score                                        8                             32.03±29.75                      101       122.37±310.06                0.414
  Maximal diameter of spleen (mm)                   4                             137.9±15.66                      101       140.36±31.26                 0.876
  Maximal diameter of splenic vein (mm)             4                             11.68±4.67                       101       10.64±3.82                   0.600
  Maximal diameter of main portal vein (mm)         8                             19.11±9.48                       105       18.33±5.07                   0.695
  In-hospital mortality -- n.                       8                             0 (0%)                           105       4 (3.7%)                     1.000

###### 

Comparison between patients with and without PVST after excluding splenectomy.

  Variables                                         PVST   No PVST                         P value                                      
  ------------------------------------------------- ------ ------------------------------- --------- ---------------------------------- -----------
  Age (years)                                       14     52.67±11.69                     91        55.60±13.22                        0.435
  Sex (Male/Female) -- n.                           14     11 (78.64%)/3 (21.4%)           91        60 (65.9%)/31 (34.1%)              0.347
  Etiology of liver diseases -- n.                  14                                     91                                           0.988
   -- Hepatitis B virus alone                              5 (35.7%)                                 27 (29.7%)                         
   -- Hepatitis C virus alone                              1 (7.1%)                                  6 (6.6%)                           
   -- Hepatitis B + C virus                                0 (0%)                                    3 (3.3%)                           
   -- Alcohol                                              5 (35.7%)                                 25 (27.5%)                         
   -- Hepatitis B virus + Alcohol                          1 (7.1%)                                  6 (6.6%)                           
   -- Hepatitis C virus + Alcohol                          0 (0%)                                    1 (1.1%)                           
   -- Autoimmunity                                         0 (0%)                                    5 (5.5%)                           
   -- Drug related                                         0 (0%)                                    2 (2.0%)                           
   -- Unknown                                              2 (14.3%)                                 16 (17.6%)                         
  Disease history -- n.                             14                                     91                                           
   -- Diabetes                                             2 (14.3%)                                 11 (12.1%)                         0.816
   -- Coronary heart disease                               0 (0%)                                    8 (8.8%)                           0.594
   -- Ischemic stroke                                      1 (7.1%)                                  4 (4.4%)                           0.518
   -- Arterial hypertension                                0 (0%)                                    9 (9.9%)                           0.604
   -- Deep vein thrombosis                                 0 (0%)                                    1 (1.1%)                           1.000
  Surgery history -- n.                             14                                     91                                           
   -- Splenectomy                                          0 (0%)                                    0 (0%)                             NA
   -- Appendicectomy                                       0 (0%)                                    3 (3.3%)                           1.000
   -- Gastric surgery                                      0 (0%)                                    2 (2.2%)                           1.000
   -- Colonic surgery                                      0 (0%)                                    1 (1.1%)                           1.000
   -- Orthopedic surgery                                   0 (0%)                                    3 (3.3%)                           1.000
  Abdominal trauma history -- n.                    14     0 (0%)                          91        1 (1.1%)                           1.000
  Acute upper gastrointestinal bleeding -- n.       14     2 (14.3%)                       91        15 (16.5%)                         0.835
  Ascites at CT scans -- n.                         14                                     91                                           0.219
   -- No                                                   4 (28.6%)                                 42 (46.2%)                         
   -- Mild                                                 6 (42.9%)                                 20 (22.0%)                         
   -- Moderate-Severe                                      4 (28.6%)                                 29 (31.9%)                         
  Hepatic encephalopathy -- n.                      14     2 (14.3%)                       90        4 (4.4%)                           0.142
  Esophageal varices at endoscopy -- n.             5                                      37                                           0.237
   -- No                                                   0 (0%)                                    10 (27.0%)                         
   -- Mild                                                 1 (20%)                                   1 (2.7%)                           
   -- Moderate                                             1 (20%)                                   8 (21.6%)                          
   -- Severe                                               3 (60%)                                   18 (48.6%)                         
  Red blood cell (10^12^/L)                         13     2.92±0.71                       89        3.49±0.89                          **0.028**
  Hemoglobin (g/L)                                  13     88.69±28.60                     89        108.73±29.84                       **0.025**
  White blood cell (10^9^/L)                        13     4.85±3.19                       89        4.98±3.23                          0.897
  Platelet count (10^9^/L)                          13     58.77±38.48                     89        97.97±79.65                        0.085
  Total bilirubin (umol/L)                          14     68.26±111.35                    90        45.36±63.99                        0.269
  Albumin (g/L)                                     14     28.65±7.28                      89        32.91±6.48                         **0.027**
  Alanine aminotransferase (U/L)                    14     46.71±64.26                     90        52.37±63.22                        0.757
  Aspartate aminotransferase (U/L)                  14     56.79±49.92                     90        76.82±103.56                       0.480
  Alakaline phosphatate (U/L)                       14     123.12±94.37                    90        116.82±78.22                       0.786
  Gamma-glutamyl transpeptidase (U/L)               14     145.00±202.98                   90        162.02±225.43                      0.791
  Blood urea nitrogen (mmol/L)                      13     6.97±3.39                       89        5.63±2.45                          0.083
  Creatinine (umol/L)                               13     71.12±29.62                     89        57.71±19.83                        **0.036**
  Potassium (mmol/L)                                13     4.05±0.51                       89        4.03±0.46                          0.880
  Sodium (mmol/L)                                   13     133.73±15.66                    89        138.64±3.51                        **0.010**
  Prothrombin time (seconds)                        13     20.25±13.12                     90        15.77±4.84                         **0.021**
  Activated partial thromboplastin time (seconds)   13     54.82±38.25                     90        43.73±10.01                        **0.023**
  International normalized ratio                    13     1.87±1.86                       90        1.28±0.55                          **0.016**
  Child-Pugh score                                  13     8.62±1.76                       87        7.49±2.08                          0.069
  Child-Pugh class A/B/C                            13     2 (15.4%)/6 (46.2%)/5 (38.5%)   87        35 (40.2%)/34 (39.1%)/18 (20.7%)   0.167
  MELD score                                        13     10.48±8.57                      87        5.60±6.62                          **0.019**
  APRI score                                        13     2.64±2.22                       89        3.37±6.56                          0.694
  AAR score                                         14     1.38±2.54                       90        1.32±1.56                          0.903
  FIB-4 score                                       13     9.19±4.71                       89        9.45±10.23                         0.928
  FI score                                          13     −20.73±7.39                     88        −25.99±6.62                        **0.010**
  King score                                        13     128.23±254.16                   88        121.70±318.66                      0.944
  Maximal diameter of spleen (mm)                   14     153.19±37.98                    91        138.28±29.25                       0.092
  Maximal diameter of splenic vein (mm)             14     11.05±4.44                      91        10.63±3.76                         0.703
  Maximal diameter of main portal vein (mm)         14     17.51±7.27                      91        18.47±4.82                         0.521
  In-hospital mortality -- n.                       14     1 (7.1%)                        91        3 (3.3%)                           0.441

###### 

Comparison between patients with and without MPV thrombosis \>50% after excluding splenectomy.

  Variables                                         MPV thrombosis \>50%   MPV thrombosis \<50% and MPV patency   P value                                      
  ------------------------------------------------- ---------------------- -------------------------------------- --------- ---------------------------------- -----------
  Age (years)                                       5                      61.13±11.72                            100       54.92±13.06                        0.300
  Sex (Male/Female) -- n.                           5                      3 (60%)/2 (40%)                        100       68 (68.0%)/32 (32.0%)              0.658
  Etiology of liver diseases -- n.                  5                                                             100                                          0.996
   -- Hepatitis B virus alone                                              2 (40%)                                          30 (30.0%)                         
   -- Hepatitis C virus alone                                              0 (0%)                                           7 (7.0%)                           
   -- Hepatitis B + C virus                                                0 (0%)                                           3 (3.0%)                           
   -- Alcohol                                                              2 (40%)                                          28 (28.0%)                         
   -- Hepatitis B virus + Alcohol                                          0 (0%)                                           7 (7.0%)                           
   -- Hepatitis C virus + Alcohol                                          0 (0%)                                           1 (1.0%)                           
   -- Autoimmunity                                                         0 (0%)                                           5 (5.0%)                           
   -- Drug related                                                         0 (0%)                                           2 (2.0%)                           
   -- Unknown                                                              1 (20%)                                          17 (17.0%)                         
  Disease history -- n.                             5                                                             100                                          
   -- Diabetes                                                             1 (20%)                                          12 (12.0%)                         0.491
   -- Coronary heart disease                                               0 (0%)                                           8 (8.0%)                           1.000
   -- Ischemic stroke                                                      1 (20%)                                          4 (4.0%)                           0.220
   -- Arterial hypertension                                                0 (0%)                                           9 (9.0%)                           1.000
   -- Deep vein thrombosis                                                 0 (0%)                                           1 (1.0%)                           1.000
  Surgery history -- n.                             5                                                             100                                          
   -- Splenectomy                                                          0 (0%)                                           0 (0%)                             NA
   -- Appendicectomy                                                       0 (0%)                                           3 (3.0%)                           1.000
   -- Gastric surgery                                                      0 (0%)                                           2 (2.0%)                           1.000
   -- Colonic surgery                                                      0 (0%)                                           1 (1.0%)                           1.000
   -- Orthopedic surgery                                                   0 (0%)                                           3 (3%)                             1.000
  Abdominal trauma history -- n.                    5                      0 (0%)                                 100       1 (1.0%)                           1.000
  Acute upper gastrointestinal bleeding -- n.       5                      1 (0%)                                 100       17 (17.0%)                         0.589
  Ascites at CT scans -- n.                         5                                                             100                                          0.080
   -- No                                                                   0 (0%)                                           46 (46.0%)                         
   -- Mild                                                                 3 (60%)                                          23 (23.0%)                         
   -- Moderate-Severe                                                      2 (40%)                                          31 (31.0%)                         
  Hepatic encephalopathy -- n.                      5                      0 (0%)                                 99        6 (6.1%)                           1.000
  Esophageal varices at endoscopy  -- n.            3                                                             38                                           0.357
   -- No                                                                   0 (0%)                                           10 (25.6%)                         
   -- Mild                                                                 0 (0%)                                           2 (5.1%)                           
   -- Moderate                                                             0 (0%)                                           8 (23.1%)                          
   -- Severe                                                               3 (100%)                                         18 (46.2%)                         
  Red blood cell (10^12^/L)                         5                      2.75±0.29                              97        3.46±0.89                          0.081
  Hemoglobin (g/L)                                  5                      72.40±8.73                             97        107.92±30.00                       **0.010**
  White blood cell (10^9^/L)                        5                      4.36±4.25                              97        4.99±3.17                          0.669
  Platelet count (10^9^/L)                          5                      52.00±32.85                            97        95.08±77.75                        0.222
  Total bilirubin (umol/L)                          5                      23.12±18.39                            99        49.72±73.35                        0.422
  Albumin (g/L)                                     5                      28.40±8.92                             98        32.53±6.59                         0.181
  Alanine aminotransferase (U/L)                    5                      15.80±6.14                             99        53.41±64.12                        0.195
  Aspartate aminotransferase (U/L)                  5                      21.80±9.50                             99        76.77±99.85                        0.223
  Alakaline phosphatate (U/L)                       5                      77.28±60.19                            99        119.71±80.67                       0.250
  Gamma-glutamyl transpeptidase (U/L)               5                      32.00±19.66                            99        166.18±225.31                      0.188
  Blood urea nitrogen (mmol/L)                      5                      8.22±5.30                              97        5.68±2.40                          **0.033**
  Creatinine (umol/L)                               5                      62.94±19.34                            97        59.24±21.80                        0.711
  Potassium (mmol/L)                                5                      4.13±0.40                              97        4.05±0.47                          0.640
  Sodium (mmol/L)                                   5                      138.84±2.15                            97        137.98±6.65                        0.773
  Prothrombin time (seconds)                        5                      16.24±3.40                             98        16.34±6.68                         0.973
  Activated partial thromboplastin time (seconds)   5                      42.02±8.12                             98        45.28±16.86                        0.669
  International normalized ratio                    5                      1.32±0.38                              98        1.35±0.86                          0.933
  Child-Pugh score                                  5                      8.20±1.30                              95        7.61±2.11                          0.538
  Child-Pugh class A/B/C                            5                      0 (0%)/4 (80%)/1 (20%)                 95        37 (38.9%)/36 (37.8%)/22 (23.2%)   0.130
  MELD score                                        5                      5.43±5.30                              95        6.27±7.15                          0.796
  APRI score                                        5                      1.28±0.69                              97        3.38±6.32                          0.462
  AAR score                                         5                      0.48±0.27                              99        1.38±1.74                          0.253
  FIB-4 score                                       5                      7.68±3.45                              97        9.51±9.90                          0.683
  FI score                                          5                      −20.92±8.87                            96        −25.54±6.78                        0.147
  King score                                        5                      39.52±21.38                            96        126.87±317.42                      0.542
  Maximal diameter of spleen (mm)                   5                      158.50±48.02                           100       139.36±29.73                       0.176
  Maximal diameter of splenic vein (mm)             5                      11.74±4.04                             100       10.63±3.84                         0.530
  Maximal diameter of main portal vein (mm)         5                      17.86±11.43                            100       18.36±5.09                         0.833
  In-hospital mortality -- n.                       5                      0 (0%)                                 100       4 (4.0%)                           1.000

###### 

Comparison between patients with and without clinically significant PVST after excluding splenectomy.

  Variables                                         Clinically significant PVST   No clinically significant PVST   P value                                      
  ------------------------------------------------- ----------------------------- -------------------------------- --------- ---------------------------------- -----------
  Age (years)                                       4                             63.59±11.96                      101       54.88±12.99                        0.191
  Sex (Male/Female) -- n.                           4                             2 (50%)/2 (50%)                  101       69 (68.3%)/32 (31.7%)              0.593
  Etiology of liver diseases -- n.                  4                                                              101                                          0.996
   -- Hepatitis B virus alone                                                     2 (50%)                                    30 (29.7%)                         
   -- Hepatitis C virus alone                                                     0 (0%)                                     7 (6.9%)                           
   -- Hepatitis B + C virus                                                       0 (0%)                                     3 (3.0%)                           
   -- Alcohol                                                                     1 (25%)                                    28 (27.7%)                         
   -- Hepatitis B virus + Alcohol                                                 0 (0%)                                     7 (6.9%)                           
   -- Hepatitis C virus + Alcohol                                                 0 (0%)                                     1 (1.0%)                           
   -- Autoimmunity                                                                0 (0%)                                     5 (5.0%)                           
   -- Drug related                                                                0 (0%)                                     2 (2.0%)                           
   -- Unknown                                                                     1 (25%)                                    17 (16.8%)                         
  Disease history -- n.                             4                                                              101                                          
   -- Diabetes                                                                    1 (25%)                                    12 (11.9%)                         0.415
   -- Coronary heart disease                                                      0 (0%)                                     8 (7.9%)                           1.000
   -- Ischemic stroke                                                             1 (25%)                                    4 (4.0%)                           0.180
   -- Arterial hypertension                                                       0 (0%)                                     9 (8.9%)                           1.000
   -- Deep vein thrombosis                                                        0 (0%)                                     1 (1.0%)                           1.000
  Surgery history -- n.                             4                                                              101                                          
   -- Splenectomy                                                                 0 (0%)                                     0 (0%)                             NA
   -- Appendicectomy                                                              0 (0%)                                     3 (3.0%)                           1.000
   -- Gastric surgery                                                             0 (0%)                                     2 (2.0%)                           1.000
   -- Colonic surgery                                                             0 (0%)                                     1 (1.0%)                           1.000
   -- Orthopedic surgery                                                          0 (0%)                                     3 (3.0%)                           1.000
  Abdominal trauma history -- n.                    4                             0 (0%)                           101       1 (1.0%)                           1.000
  Acute upper gastrointestinal bleeding -- n.       4                             1 (12.5%)                        101       17 (16.8%)                         1.000
  Ascites at CT scans -- n.                         4                                                              101                                          **0.047**
   -- No                                                                          0 (0%)                                     46 (45.5%)                         
   -- Mild                                                                        3 (75%)                                    23 (22.8%)                         
   -- Moderate-Severe                                                             1 (25%)                                    32 (31.7%)                         
  Hepatic encephalopathy -- n.                      4                             0 (0%)                           101       6 (6.0%)                           1.000
  Esophageal varices at endoscopy -- n.             2                                                              40                                           0.552
   -- No                                                                          0 (0%)                                     10 (25%)                           
   -- Mild                                                                        0 (0%)                                     2 (5%)                             
   -- Moderate                                                                    0 (0%)                                     9 (22.5%)                          
   -- Severe                                                                      2 (100%)                                   19 (47.5%)                         
  Red blood cell (10^12^/L)                         4                             2.79±0.32                        98        3.45±0.89                          0.145
  Hemoglobin (g/L)                                  4                             72.5±10.08                       98        107.55±30.07                       **0.023**
  White blood cell (10^9^/L)                        4                             5±4.62                           98        4.96±3.17                          0.981
  Platelet count (10^9^/L)                          4                             61±29.98                         98        94.28±77.77                        0.397
  Total bilirubin (umol/L)                          4                             26.48±19.38                      100       49.32±73.09                        0.536
  Albumin (g/L)                                     4                             25.9±8.03                        99        32.59±6.58                         0.050
  Alanine aminotransferase (U/L)                    4                             17±6.38                          100       52.99±63.94                        0.265
  Aspartate aminotransferase (U/L)                  4                             23.75±9.74                       100       76.14±99.54                        0.297
  Alakaline phosphatate (U/L)                       4                             84.6±66.88                       100       118.99±80.58                       0.402
  Gamma-glutamyl transpeptidase (U/L)               4                             33.75±22.25                      100       164.77±224.61                      0.248
  Blood urea nitrogen (mmol/L)                      4                             8.96±5.81                        98        5.67±2.37                          **0.013**
  Creatinine (umol/L)                               4                             65.93±20.97                      98        59.16±21.70                        0.542
  Potassium (mmol/L)                                4                             4.03±0.38                        98        4.04±0.47                          0.969
  Sodium (mmol/L)                                   4                             138.5±2.32                       98        138.00±6.62                        0.881
  Prothrombin time (seconds)                        4                             16.6±3.81                        99        16.33±6.65                         0.935
  Activated partial thromboplastin time (seconds)   4                             40.9±8.92                        99        45.30±16.77                        0.605
  International normalized ratio                    4                             1.36±0.43                        99        1.35±0.85                          0.983
  Child-Pugh score                                  4                             8.5±1.29                         96        7.60±2.10                          0.400
  Child-Pugh class A/B/C                            4                             0 (0%)/3 (75%)/1 (25%)           96        37 (38.5%)/37 (38.5%)/22 (22.9%)   0.244
  MELD score                                        4                             6.69±5.18                        96        6.21±7.13                          0.895
  APRI score                                        4                             1.06±0.54                        98        3.37±6.29                          0.466
  AAR score                                         4                             0.47±0.32                        100       1.37±1.73                          0.303
  FIB-4 score                                       4                             6.22±1.25                        98        9.58±9.86                          0.503
  FI score                                          4                             −18.51±8.14                      97        −25.59±6.77                        **0.044**
  King score                                        4                             36.38±23.32                      97        126.10±315.86                      0.573
  Maximal diameter of spleen (mm)                   4                             137.9±15.66                      101       140.36±31.26                       0.876
  Maximal diameter of splenic vein (mm)             4                             11.68±4.67                       101       10.64±3.82                         0.600
  Maximal diameter of main portal vein (mm)         4                             18.6±13.06                       101       18.33±4.78                         0.919
  In-hospital mortality -- n.                       4                             0 (0%)                           101       4 (4.0%)                           1.000

###### 

Comparison between PVST patients with and without splenectomy.

  Variables                                           Splenectomy   No splenectomy           P value                                   
  --------------------------------------------------- ------------- ------------------------ --------- ------------------------------- -------------
  Age (years)                                         5             54.46±14.98              14        52.67±11.69                     0.787
  Sex (Male/Female) -- n.                             5             2 (40%)/3 (60%)          14        11 (78.6%)/3 (21.4%)            0.111
  Etiology of liver diseases -- n.                    5                                      14                                        0.059
   -- Hepatitis B virus alone                                       0 (0%)                             5 (35.7%)                       
   -- Hepatitis C virus alone                                       0 (0%)                             1 (7.1%)                        
   -- Hepatitis B + C virus                                         1 (20%)                            0 (0%)                          
   -- Alcohol                                                       0 (0%)                             5 (35.7%)                       
   -- Hepatitis B virus + Alcohol                                   2 (40%)                            1 (7.1%)                        
   -- Hepatitis C virus + Alcohol                                   0 (0%)                             0 (0%)                          
   -- Hepatitis B + C virus + Alcohol                               0 (0%)                             0 (0%)                          
   -- Autoimmunity                                                  1 (20%)                            0 (0%)                          
   -- Drug related                                                  0 (0%)                             0 (0%)                          
   -- Unknown                                                       1 (20%)                            2 (14.3%)                       
  Disease history -- n.                               5                                      14                                        
   -- Diabetes                                                      1 (20%)                            2 (14.3%)                       0.764
   -- Coronary heart disease                                        0 (0%)                             0 (0%)                          NA
   -- Ischemic stroke                                               0 (0%)                             1 (7.1%)                        1.000
   -- Arterial hypertension                                         0 (0%)                             0 (0%)                          NA
   -- Deep vein thrombosis                                          0 (0%)                             0 (0%)                          NA
  Surgery history -- n.                               5                                      14                                        
   -- Appendicectomy                                                0 (0%)                             0 (0%)                          NA
   -- Gastric surgery                                               0 (0%)                             0 (0%)                          NA
   -- Colonic surgery                                               0 (0%)                             0 (0%)                          NA
   -- Orthopedic surgery                                            0 (0%)                             0 (0%)                          NA
  Abdominal trauma history -- n.                      5             0 (0%)                   14        0 (0%)                          NA
  Acute upper gastrointestinal bleeding -- n.         5             1 (20%)                  14        2 (14.3%)                       0.764
  Ascites at CT scans -- n.                           5                                      14                                        0.805
   -- No                                                            1 (20%)                            4 (28.6%)                       
   -- Mild                                                          3 (60%)                            6 (42.9%)                       
   -- Moderate-Severe                                               1 (20%)                            4 (28.6%)                       
  Hepatic encephalopathy -- n.                        5             0 (0%)                   14        2 (14.3%)                       0.372
  Esophageal varices at endoscopy -- n.               5                                      5                                         0.565
   -- No                                                            0 (0%)                             0 (0%)                          
   -- Mild                                                          1 (20%)                            1 (20%)                         
   -- Moderate                                                      0 (0%)                             1 (20%)                         
   -- Severe                                                        4 (80%)                            2 (60%)                         
  Red blood cell (10^12^/L)                           5             2.7±0.45                 13        2.92±0.71                       0.532
  Hemoglobin (g/L)                                    5             73.2±20.08               13        88.69±28.60                     0.287
  White blood cell (10^9^/L)                          5             6.24±2.82                13        4.85±3.19                       0.408
  Platelet count (10^9^/L)                            5             244.4±93.79              13        58.77±38.48                     **\<0.001**
  Total bilirubin (umol/L)                            5             19.84±20.41              14        68.26±111.35                    0.356
  Albumin (g/L)                                       5             31.54±4.27               14        28.65±7.28                      0.419
  Alanine aminotransferase (U/L)                      5             58.6±44.99               14        46.71±64.26                     0.710
  Aspartate aminotransferase (U/L)                    5             83.2±72.98               14        56.79±49.92                     0.380
  Alakaline phosphatate (U/L)                         5             160.36±198.16            14        123.12±94.37                    0.580
  Gamma-glutamyl transpeptidase (U/L)                 5             96±136.71                14        145±202.98                      0.626
  Blood urea nitrogen (mmol/L)                        5             4.18±2.16                13        6.97±3.39                       0.109
  Creatinine (umol/L)                                 5             49.3±3.46                13        71.12±29.62                     0.126
  Potassium (mmol/L)                                  5             3.99±0.35                13        4.05±0.51                       0.804
  Sodium (mmol/L)                                     5             138.4±3.40               13        133.73±15.66                    0.525
  Prothrombin time (seconds)                          5             14.7±2.71                13        20.25±13.12                     0.371
  Activated partial thromboplastin time (seconds)     5             35.16±4.22               13        54.82±38.25                     0.277
  International normalized ratio                      5             1.18±0.28                13        1.87±1.86                       0.427
  Child-Pugh score                                    5             7.4±1.52                 13        8.62±1.76                       0.193
  Child-Pugh class A/B/C                              5             2 (40%)/3 (60%)/0 (0%)   13        2 (15.4%)/7 (53.8%)/4 (30.8%)   0.280
  MELD score                                          5             1.32±5.02                13        10.48±8.57                      **0.041**
  APRI score                                          5             1.11±1.12                13        2.64±2.22                       0.165
  AAR score                                           5             0.52±0.35                14        1.38±2.54                       0.468
  FIB-4 score                                         5             2.72±1.91                13        9.19±4.71                       **0.010**
  FI score                                            5             −25.98±4.72              13        −20.73±7.39                     0.163
  King score                                          5             29.97±33.61              13        128.23±254.16                   0.410
  According to the location of thrombosis             5                                      14                                        
   -- Left portal vein branch thrombosis -- n.                      3 (60%)                            4 (28.6%)                       0.211
   -- Right portal vein branch thrombosis -- n.                     4 (80%)                            2 (14.3%)                       **0.007**
   -- Main portal vein thrombosis -- n.                             5 (100%)                           9 (64.3%)                       0.120
   -- Superior mesenteric vein thrombosis -- n.                     5 (4.8%)                           4 (28.6%)                       0.089
   -- Splenic vein thrombosis -- n.                                 NA                                 4 (28.6%)                       NA
  According to the degree of MPV thrombosis           5                                      14                                        0.207
   -- Mural thrombosis (\<50%) -- n.                                1 (20%)                            4 (28.6%)                       
   -- Partial thrombosis (\>50%) -- n.                              2 (40%)                            4 (28.6%)                       
   -- Total thrombosis (100%) -- n.                                 2 (40%)                            1 (7.1%)                        
  Cavernous transformation of the portal vein -- n.   5             2 (40%)                  14        3 (21.4%)                       0.418
  Clinically significant PVST -- n.                   5             4 (80%)                  14        4 (28.6%)                       **0.046**
  Maximal diameter of spleen (mm)                     5             NA                       14        153.19±37.98                    NA
  Maximal diameter of splenic vein (mm)               5             NA                       14        11.05±4.39                      NA
  Maximal diameter of main portal vein (mm)           5             18.18±6.27               14        17.51±7.27                      0.857
  In-hospital mortality -- n.                         5             0 (0%)                   14        1 (7.1%)                        0.539
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